ARTICLE | Clinical News
PC-DAC: Exendin-4: Phase I/II start
August 29, 2005 7:00 AM UTC
CJC will start in 1Q06 a single-dose, dose-escalation Phase I/II trial in 33-55 patients. ...
Upcoming Login Downtime
We're updating the Biocentury.com platform login experience to make access more secure and reliable. As part of this update, logins will be temporarily unavailable on Sunday, March 16, from 4:00AM to 4:00PM GMT. We recognize the inconvenience and appreciate your understanding. Please check back after the maintenance period.
For updates, questions, or issues, please call us at +1 650-552-4224 or email us at support@biocentury.com.
CJC will start in 1Q06 a single-dose, dose-escalation Phase I/II trial in 33-55 patients. ...